BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• FDA

  Suven Life Sciences Ltd’s Unit-III Receives US FDA Acceptance

  April 5, 2011

   · 

  1 min read
• Drug Development

  Genzyme Corporation: Data from Two Mipomersen Phase 3 Trials Presented at ACC

  April 5, 2011

   · 

  1 min read
• Business

  BTG plc: Close Period Update

  April 5, 2011

   · 

  5 min read
• Deals

  European Commission Approves DuPont Tender Offer to Acquire Danisco

  April 5, 2011

   · 

  4 min read
• Business

  Aragen Bioscience, Inc. Awarded Three Preclinical Development NIAID Subcontracts

  April 5, 2011

   · 

  1 min read
• Pharm Country

  MannKind Corporation Posters Win Awards from International Pharmaceutical Aerosol Consortium on Regulation and Science

  April 5, 2011

   · 

  1 min read
• Drug Development

  Jennerex and TRANSGENE Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors

  April 5, 2011

   · 

  6 min read
• Drug Development

  Johnson & Johnson Pharmaceutical Research & Development, LLC (CA): In Study of Acutely Ill Patients Rivaroxaban Compares Favorably With Enoxaparin in Preventing Venous Thromboembolism but With an Increased Rate of Bleeding

  April 5, 2011

   · 

  1 min read
• Business

  Newron Pharmaceuticals Reports 2010 Results

  April 5, 2011

   · 

  12 min read
• Deals

  Morphotek Inc. Announces Acquisition of Tumor Targeting Assets From TransMolecular, Inc.

  April 5, 2011

   · 

  3 min read